ZIMMER BIOMET HOLDINGS, INC. - 10-Q Filing

Zimmer Biomet reports Q3 2026 results including updates on the 2025 Restructuring Plan and Monogram Technologies acquisition.

SEC EDGAR ·

Tickers: $ZBH

Read the full article at SEC EDGAR

More Regulatory news